semaglutide air bubble in GLP-1 Syringe: Safety Facts and Removal Guide How to Prepare for Your

Dose may be increased to 9 mg once daily if additional glycemic control is needed after at least 30 days on the 4 mg dose

Learn more about the differences between semaglutide products

Genetics, age, sex, and health conditions affect semaglutide dosage

Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)

The FDA-approved maximum for weight loss is 2.4 mg weekly, though some patients achieve significant results at lower doses such as 0.5 mg, 1.0 mg, or 1.7 mg